Home Company Technology Platform Products and Services Contact
Publications References


We set new standards in the expression of heterologous glycoproteins

EUGENEX developed a well-characterized expression system (cell lines, vector, media) to serve the customer's needs for
  • safety
  • economy
  • speed
in the production of pure heterologous glycoproteins for research, diagnostics and therapeutic applications.

The absence of serum and animal-derived components during all steps of development increases biosafety and leads to safer products in protein expression.

Beside economical and biosafety aspects there are also ethical consideration concerning the use of fetal bovine serum. Klick here and here to learn more about the harvest procedure of FBS.


copyright EUGENEX Biotechnologies GmbH
 imprint  ·  eMail: info@eugenex.com
 realized by HORNUNG